Stimuli-Responsive Nanomedicine as New Generation Therapeutic Agents
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (30 July 2021) | Viewed by 437
Special Issue Editors
Interests: ribonuclease; small noncoding RNA; pathogen; 2D nanomaterials; antibiotic resistance; synergistic antibiotics; gene expression; biofilm; extracellular vesicles; proteomics; transcriptomics; vaccine platform
Special Issues, Collections and Topics in MDPI journals
Interests: nanomaterials; antimicrobial agents; action mechanisms; anticancer drug; photothermal therapeutics; photothermal agents; stimuli-responsive materials; nanoplatform; target specificity; new-concept antimicrobials; new-concept anticancer agents
Special Issue Information
Dear Colleagues,
As cutting-edge anticancer and antimicrobial agents, nanomaterials have been extensively used in pharmaceutics as alternative therapeutic modalities to established therapeutics. In particular, functionalized nanomaterials with stimuli-responsive (endogenous and exogenous) properties have been synthesized as a nanoplatform and used for different biomedical applications. Nevertheless, further studies must be conducted to develop new nanoplatforms that optimize the potential of these stimuli-responsive nanomaterials with good biocompatibility and clinical optimization. This Special Issue will shed light on the use of stimuli-responsive nanomaterials as potential candidates for various biomedical applications, especially as anticancer and antimicrobial agents, and draw the scientific community’s attention to further challenges and avenues of research in this field. Authors are invited to submit original research articles and reviews in this important and exciting research field.
Prof. Dr. Kwang-sun Kim
Dr. Atanu Naskar
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- endogenous stimuli (redox, pH, enzyme, and others) responsive
- exogenous stimuli (temperature, light, magnetic, and others) responsive
- eanomaterials with antibiotics
- eiomedical applications
- ennovative therapeutic nanomedicine
